These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

737 related items for PubMed ID: 15673617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
    Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH, STEP-BD Investigators.
    J Clin Psychopharmacol; 2004 Oct; 24(5):512-20. PubMed ID: 15349007
    [Abstract] [Full Text] [Related]

  • 3. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
    McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, Nolen WA, Kupka RW, Leverich GS, Rochussen JR, Rush AJ, Post RM.
    Am J Psychiatry; 2001 Mar; 158(3):420-6. PubMed ID: 11229983
    [Abstract] [Full Text] [Related]

  • 4. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH, Dunner DL.
    Depress Anxiety; 2008 Mar; 25(2):91-7. PubMed ID: 17311265
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.
    Singh JB, Zarate CA.
    Bipolar Disord; 2006 Dec; 8(6):696-709. PubMed ID: 17156156
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M.
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, Schaffer A, Connolly M, Gorman CP, Canadian Network for Mood and Anxiety Treatments.
    Bipolar Disord; 2005 Mar; 7 Suppl 3():5-69. PubMed ID: 15952957
    [Abstract] [Full Text] [Related]

  • 10. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G, Albert U, Pessina E, Bogetto F.
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A, Wagner S, Hoch J, Başkaya O, von Cube R, Skaletz C, Lieb K, Dahmen N.
    Psychopathology; 2009 Nov; 42(4):257-63. PubMed ID: 19521142
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Nov; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R.
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [Abstract] [Full Text] [Related]

  • 16. Developmental pathways for different subtypes of early-onset bipolarity in youths.
    Masi G, Mucci M, Pfanner C, Berloffa S, Magazù A, Perugi G.
    J Clin Psychiatry; 2012 Oct; 73(10):1335-41. PubMed ID: 23058936
    [Abstract] [Full Text] [Related]

  • 17. Diagnosing and treating comorbid (complicated) bipolar disorder.
    McElroy SL.
    J Clin Psychiatry; 2004 Oct; 65 Suppl 15():35-44. PubMed ID: 15554795
    [Abstract] [Full Text] [Related]

  • 18. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
    Vélez-Pastrana MC, González RA, Ramos-Fernández A, Ramírez Padilla RR, Levin FR, Albizu García C.
    Eur Addict Res; 2020 Oct; 26(4-5):179-190. PubMed ID: 32615575
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K, Muzina D, Gajwani P, Calabrese JR.
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.